BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36117311)

  • 1. Factors associated with the development of second primary tumours in head and neck cancer patients.
    Salcedo-Bellido I; Requena P; Mateos R; Ortega-Rico C; Olmedo-Requena R; Lozano-Lorca M; Arrebola JP; Barrios-Rodríguez R
    Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13699. PubMed ID: 36117311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Modality and Second Primary Tumors of the Head and Neck.
    Ben Arie G; Shafat T; Belochitski O; El-Saied S; Joshua BZ
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(6):420-427. PubMed ID: 34587611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of second primary tumors in head and neck cancer: A systematic review.
    Coca-Pelaz A; Rodrigo JP; Suárez C; Nixon IJ; Mäkitie A; Sanabria A; Quer M; Strojan P; Bradford CR; Kowalski LP; Shaha AR; de Bree R; Hartl DM; Rinaldo A; Takes RP; Ferlito A
    Head Neck; 2020 Mar; 42(3):456-466. PubMed ID: 31750595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Smoking Cessation and Continuation on Recurrence and Survival in Patients with Head and Neck Cancer: A Systematic Review of the Literature.
    von Kroge PR; Bokemeyer F; Ghandili S; Bokemeyer C; Seidel C
    Oncol Res Treat; 2020; 43(10):549-558. PubMed ID: 32950990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of metachronous second primary cancer in head and neck cancer survivors: A systematic review and meta-analysis of the literature.
    Hoxhaj I; Hysaj O; Vukovic V; Leoncini E; Amore R; Pastorino R; Boccia S
    Eur J Cancer Care (Engl); 2020 Sep; 29(5):e13255. PubMed ID: 32400912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefits from endoscopy screening of esophageal second primary tumor for head and neck cancer patients: Analysis of a hospital-based registry.
    Chung CS; Lo WC; Chen KC; Lin CL; Wen MH; Hsieh CH; Lin SC; Liao LJ
    Oral Oncol; 2019 Sep; 96():27-33. PubMed ID: 31422210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cause-specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study.
    Bugter O; van Iwaarden DLP; van Leeuwen N; Nieboer D; Dronkers EAC; Hardillo JAU; Baatenburg de Jong RJ
    Head Neck; 2021 Jun; 43(6):1881-1889. PubMed ID: 33655596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
    Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
    Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: a single centre study in 987 patients.
    Farhadieh RD; Salardini A; Yang JL; Russell P; Smee R
    J Surg Oncol; 2010 Jan; 101(1):72-7. PubMed ID: 19798688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple primary tumours following head and neck cancer in southern England during 1961-98.
    Warnakulasuriya KA; Robinson D; Evans H
    J Oral Pathol Med; 2003 Sep; 32(8):443-9. PubMed ID: 12901724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and prognostic factors in patients with head and neck cancer: Results from a multicentric study.
    Leoncini E; Vukovic V; Cadoni G; Pastorino R; Arzani D; Bosetti C; Canova C; Garavello W; La Vecchia C; Maule M; Petrelli L; Pira E; Polesel J; Richiardi L; Serraino D; Simonato L; Ricciardi W; Boccia S
    Cancer Epidemiol; 2015 Jun; 39(3):367-74. PubMed ID: 25770642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
    Jung YS; Lim J; Jung KW; Ryu J; Won YJ
    PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
    Iwatsubo T; Ishihara R; Morishima T; Maekawa A; Nakagawa K; Arao M; Ohmori M; Iwagami H; Matsuno K; Inoue S; Nakahira H; Matsuura N; Shichijo S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Miyashiro I; Higuchi K; Fujii T
    BMC Cancer; 2019 Jan; 19(1):3. PubMed ID: 30606157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second primary tumours in head and neck cancer.
    Herranz González-Botas J; Varela Vázquez P; Vázquez Barro C
    Acta Otorrinolaringol Esp; 2016; 67(3):123-9. PubMed ID: 26386656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Gastrointestinal Stromal Tumors and Other Malignancies: It Is Only a Matter of Time ? A Case Series and an Overview of Systematic Reviews.
    Podda M; Ferraro G; Di Saverio S; Cois A; Nardello O; Poillucci G; Marino MV; Pisanu A
    J Gastrointest Cancer; 2020 Sep; 51(3):914-924. PubMed ID: 31713047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis.
    Rubió-Casadevall J; Galceran J; Ameijide A; Puigdemont M; Llauradó L; Marruecos J; Izquierdo A; Carulla M; Borràs JL; Marcos-Gragera R; Gumà J
    Clin Transl Oncol; 2021 Apr; 23(4):788-798. PubMed ID: 32815088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis.
    Dai D; Tian Q; Shui Y; Li J; Wei Q
    Radiother Oncol; 2022 Mar; 168():28-36. PubMed ID: 35017020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis.
    Wong A; Zhu D; Kraus D; Tham T
    Laryngoscope; 2021 Feb; 131(2):333-341. PubMed ID: 32220072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
    Budnik J; DeNunzio NJ; Singh DP; Milano MT
    Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.